Table: begin end state 1 11 non-cytoplasmic 12 43 transmembrane 44 55 cytoplasmic 56 80 transmembrane 81 103 non-cytoplasmic 104 134 transmembrane 135 145 cytoplasmic 146 170 transmembrane 171 181 non-cytoplasmic 182 206 transmembrane 207 225 cytoplasmic 226 252 transmembrane 253 257 non-cytoplasmic 258 276 transmembrane 277 289 cytoplasmic 290 310 transmembrane 311 329 non-cytoplasmic 330 350 transmembrane 351 351 cytoplasmic 352 398 transmembrane 399 404 non-cytoplasmic 405 408 cytoplasmic 409 410 non-cytoplasmic 411 433 transmembrane 434 497 non-cytoplasmic
Input: >WP_020922288.1 NCBI__GCF_000092045.1:WP_020922288.1 MFDFGIIPPAMFLGMVIFMLYGFPVAFSLAAVGMFFGIIGIVTGHFSEAFLQALPLRFFG IVSNDLLLAIPFFTLMGAVLERCGLAEDLLEGTGKLFGGIPGGLAYAVILVGAVLGAITG TVAASVITMGVISLPIMLRYGYSPRLATGVIAASGTITQVIPPSLVLVVLADQLGRSVGD MYLGAIGPSILQVTIFVLFVLVMSIVRPKSMPPLPKEVRGDFNWALLVKVLMGMVPSIVL IFLVLGTIFMGLATPTEAGALGVVGAMLLAAMNRRLTWPLIREAMTSTTHITSMVVMILI GSTCFSLVFQGMDGSRWIEHMLSGIPGGPVGFLIFVNIFIFVLAFFLDFFEIAFIVIPML APVASSLGIDLIWFGVLICVNMQTSFMHPPFGFALFYLRSIASKDVKTSDIYMGALPWVG MQIILVAIVIFWPQSVTYWLDHGPKVDPNSIKIEVPGFGGQLGLPPVGGGGNGAPQIPGL TLPPLNGLPGAPPPPAK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server